Nuclear matrix protein 22 tests

Recombinant protein fragment of Human USP28 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human USP28 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human USP37 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human USP38&nbspwith&nbspN-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag.&nbsp &nbsp&nbsp Application Blocking agent and positive assay control using

Recombinant protein fragment of Human USP48 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human USP48 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen UTP20 UTP20 small subunit (SSU) processome com

PrEST Antigen UTP23 UTP23, small subunit (SSU) processome co

PrEST Antigen UTP3 UTP3, small subunit (SSU) processome comp

PrEST Antigen UTP3 UTP3, small subunit (SSU) processome comp

Recombinant protein fragment of Human VPS26A with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human VPS28 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.